Stoke Therapeutics Inc’s recent filing unveils that its COO & CBO Nash Huw M. unloaded Company’s shares for reported $0.81 million on Apr 01 ’24. In the deal valued at $13.23 per share,61,329 shares were sold. As a result of this transaction, Nash Huw M. now holds 0 shares worth roughly $0.0.
Then, Ticho Barry sold 9,426 shares, generating $124,684 in total proceeds. Upon selling the shares at $13.23, the CHIEF MEDICAL OFFICER now owns 2,485 shares.
Before that, Allan Jonathan sold 5,126 shares. Stoke Therapeutics Inc shares valued at $67,668 were divested by the GENERAL COUNSEL & CORP SEC at a price of $13.20 per share. As a result of the transaction, Allan Jonathan now holds 2,598 shares, worth roughly $32656.86.
TD Cowen upgraded its Stoke Therapeutics Inc [STOK] rating to an Outperform from a a Market perform in a research note published recently. TD Cowen also remained covering STOK and has decreased its forecast on July 25, 2023 with a “Market perform” recommendation from previously “an Outperform” rating. BofA Securities revised its rating on May 01, 2023. It rated STOK as “a Neutral” which previously was an “an Underperform”.
Price Performance Review of STOK
On Friday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock jump 3.29% to $12.57. Over the last five days, the stock has lost -6.89%. Stoke Therapeutics Inc shares have risen nearly 138.97% since the year began. Nevertheless, the stocks have risen 56.34% over the past one year. While a 52-week high of $16.40 was reached on 03/27/24, a 52-week low of $3.35 was recorded on 02/13/24. SMA at 50 days reached $7.03, while 200 days put it at $6.04. A total of 0.64 million shares were traded, compared to the trading of 1.38 million shares in the previous session.
Levels Of Support And Resistance For STOK Stock
The 24-hour chart illustrates a support level at 11.96, which if violated will result in even more drops to 11.35. On the upside, there is a resistance level at 13.02. A further resistance level may holdings at 13.47. The Relative Strength Index (RSI) on the 14-day chart is 69.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.61, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 35.46%. Stochastics %K at 64.06% indicates the stock is a holding.
How much short interest is there in Stoke Therapeutics Inc?
A steep rise in short interest was recorded in Stoke Therapeutics Inc stocks on Mar 15, 2024, dropping by -0.42 million shares to a total of 3.55 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 3.97 million shares. There was a decline of -11.83%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 12.21% of the overall stock float, the days-to-cover ratio (short ratio) fell to 12.07.
